Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized Open-Label Phase II Study of the Safety and Tolerability of Metformin in Combination With Standard Antimicrobial Treatment of Pulmonary Tuberculosis in People Co-infected With HIV

NCT04930744 is registered in ClinicalTrials.gov with University of Massachusetts, Worcester as lead sponsor.

NCT NCT04930744
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04930744 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized Open-Label Phase II Study of the Safety and Tolerability of Metformin in Combination With Standard Antimicrobial Treatment of Pulmonary Tuberculosis in People Co-infected With HIV
Lead sponsor
University of Massachusetts, Worcester
Phase
Phase 2
Overall status
Completed
Start date
March 4, 2022
Completion date
August 15, 2025
Enrollment
112 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hiv coinfection, pulmonary tuberculosis, tuberculosis